on SynBiotic SE (isin : DE000A3E5A59)
European Hemp and Cannabis Developments Highlighted at ICBC Berlin
SYNBIOTIC SE, a significant player in the European cannabis sector, and GOC NEXUS, known for their microbiological decontamination processes, will present at the International Cannabis Business Conference (ICBC) in Berlin on April 29-30. Their collaboration, initiated in December 2024, focuses on advancing medicinal cannabis standards.
CEO Daniel Kruse advocates for maintaining cannabis as medicine amidst potential political changes following Germany’s 2025 federal election. He emphasizes the importance of industrial hemp in job creation, urging action against legal hurdles, particularly the ‘intoxication clause’ which hampers industry growth.
With Germany’s recent cannabis legalization, the market could surpass one billion euros by 2028, but political shifts risk stalling this progress. SYNBIOTIC plans to introduce a new medicinal cannabis dosage form, amidst its current strong performance figures.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SynBiotic SE news